| MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU E Favaro, A Ramachandran, R McCormick, H Gee, C Blancher, M Crosby, ... PloS one 5 (4), e10345, 2010 | 350 | 2010 |
| The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis HE Gee, FM Buffa, C Camps, A Ramachandran, R Leek, M Taylor, M Patil, ... British journal of cancer 104 (7), 1168-1177, 2011 | 349 | 2011 |
| Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization Y del Pozo Martin, D Park, A Ramachandran, L Ombrato, F Calvo, ... Cell reports 13 (11), 2456-2469, 2015 | 226 | 2015 |
| TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition A Ramachandran, P Vizan, D Das, P Chakravarty, J Vogt, KW Rogers, ... Elife 7, e31756, 2018 | 153 | 2018 |
| Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes E Grönroos, IJ Kingston, A Ramachandran, RA Randall, P Vizán, CS Hill Molecular and cellular biology 32 (14), 2904-2916, 2012 | 111 | 2012 |
| Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis C Blick, A Ramachandran, R McCormick, S Wigfield, D Cranston, J Catto, ... British journal of cancer 113 (4), 634-644, 2015 | 96 | 2015 |
| Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer C Blick, A Ramachandran, S Wigfield, R McCormick, A Jubb, FM Buffa, ... British journal of cancer 109 (1), 50-59, 2013 | 83 | 2013 |
| Cadherin-17 is required to maintain pronephric duct integrity during zebrafish development J Horsfield, A Ramachandran, K Reuter, E LaVallie, L Collins-Racie, ... Mechanisms of development 115 (1-2), 15-26, 2002 | 77 | 2002 |
| Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma GNJ Betts, A Eustace, S Patiar, HR Valentine, J Irlam, A Ramachandran, ... European journal of cancer 49 (1), 156-165, 2013 | 45 | 2013 |
| Activin is a potent growth suppressor of epithelial ovarian cancer cells A Ramachandran, ES Marshall, DR Love, BC Baguley, AN Shelling Cancer letters 285 (2), 157-165, 2009 | 31 | 2009 |
| Pathogenic ACVR1R206H activation by Activin A‐induced receptor clustering and autophosphorylation A Ramachandran, M Mehić, L Wasim, D Malinova, I Gori, BK Blaszczyk, ... The EMBO journal 40 (14), e106317, 2021 | 25 | 2021 |
| An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3 A Ramachandran, G Betts, S Bhana, G Helme, C Blick, C Moller-Levet, ... European Journal of Cancer 49 (7), 1741-1751, 2013 | 18 | 2013 |
| TGF-beta inhibits BMP-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes E Gronroos, IJ Kingston, A Ramachandran, RA Randall, P Vizan, CS Hill Mol Cell Biol 32, 2904-2916, 2012 | 4 | 2012 |
| Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization. Cell Rep 13: 2456–2469 Y del Pozo Martin, D Park, A Ramachandran, L Ombrato, F Calvo, ... | 3 | 2015 |
| Dissecting the role of activin in ovarian cancer A Ramachandran University of Auckland, 2007 | 2 | 2007 |
| Clinically Relevant Biology of Hyaluronic Acid in the Desmoplastic Stroma of Pancreatic Ductal Adenocarcinoma H Jahedi, A Ramachandran, J Windsor, N Knowlton, C Blenkiron Pancreas 51 (9), 1092-1104, 2022 | | 2022 |
| Mechanistic Insights into Deregulated TGF‐β Family Signalling in Human Disease CS Hill, I Gori, S Kjaer, R George, A Ramachandran, M Mehic, P Tolar, ... The FASEB Journal 36, 2022 | | 2022 |
| Hypoxia regulated miRNAs in bladder cancer C Blick, A Ramachandran, D Cranston, J Catto, A Harris | | 2012 |
| Abstract LB-440: Low density array profiling of head and neck squamous cell carcinoma utilizing a 25-gene signature can reliably identify hypoxic tumors A Williamson, GNJ Betts, S Patiar, HR Valentine, JJ Irlam, ... Cancer Research 72 (8_Supplement), LB-440-LB-440, 2012 | | 2012 |
| The role of vHL and REDD1 in predicting sensitivity to targeted therapies in renal cell carcinoma C Blick, A Ramachandran, R McCormick, D Cranston, AL Harris Cancer Research 72 (8_Supplement), 3942-3942, 2012 | | 2012 |
